Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/52618
DC FieldValueLanguage
dc.contributor.authorOjeda, Soledaden_US
dc.contributor.authorPan, Manuelen_US
dc.contributor.authorSuárez de Lezo, Javieren_US
dc.contributor.authorMazuelos, Franciscoen_US
dc.contributor.authorRomero, Miguelen_US
dc.contributor.authorNovoa, Joséen_US
dc.contributor.authorEspejo, Simonaen_US
dc.contributor.authorSegura, Joséen_US
dc.contributor.authorMorenate, Carmenen_US
dc.contributor.authorMedina, Alfonsoen_US
dc.contributor.authorMartin, Pedroen_US
dc.contributor.authorSuarez de Lezo, Joseen_US
dc.date.accessioned2018-12-05T09:57:44Z-
dc.date.available2018-12-05T09:57:44Z-
dc.date.issued2016en_US
dc.identifier.issn1774-024Xen_US
dc.identifier.otherWoS-
dc.identifier.otherScopus-
dc.identifier.urihttp://hdl.handle.net/10553/52618-
dc.description.abstractAims: The behaviour of side branches (SBs) covered by a bioresorbable vascular scaffold (BVS) is not well known. This study analysed the rate of side branch occlusion (SBO) immediately after BVS implantation, its clinical impact, predictors of SBO and the fate of such SBs at follow-up. Methods and results: We assessed 140 patients with 346 jeopardised SBs divided into three groups: small (<1 mm, n=181), intermediate (1-2 mm, n=102) and large (>2 mm, n=63). SBO was defined as a TIMI flow 0 or 1. Computed tomography was scheduled at six months for patients with jailed SBs >1 mm. Immediate occlusion occurred in 31 (9%) SBs: 22 (12%) small, 8 (8%) intermediate and one (1.6%) large, while post-procedural SBO was 5.5%. In-hospital events included one thrombosis (0.7%) and eight non-Q-wave myocardial infarctions (6%). After 17±3 months, one patient died (0.7%) and six patients needed repeat revascularisation (4%). Re-evaluation showed no late SBO at 7±3 months. Predictors of SBO were: small SBs (OR 2.06, 95% CI: 1.08-4.63; p<0.05) and stenosis >50% at the origin (OR 17.22, 95% CI: 7.79-38.10; p<0.01). Conclusions: The incidence of SBO and its clinical impact were low when SBs >1 mm were covered. These favourable results were maintained at midterm.en_US
dc.languageengen_US
dc.relation.ispartofEuroInterventionen_US
dc.sourceEuroIntervention [ISSN 1774-024X], v. 11 (11), p. e1283-e1290, (Febrero 2016)en_US
dc.subject32 Ciencias médicasen_US
dc.subject.otherAngiographyen_US
dc.subject.otherBifurcationen_US
dc.subject.otherBioresorbable vascular scaffolden_US
dc.subject.otherCoronaryen_US
dc.subject.otherMultislice computed tomography (MSCT)en_US
dc.subject.otherPercutaneous coronary intervention (PCI)en_US
dc.subject.otherSide branch occlusionen_US
dc.titlePatency of coronary side branches covered by an everolimus-eluting bioresorbable vascular scaffold: clinical outcomes and computed tomography scan follow-upen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.4244/EIJV11I11A250en_US
dc.identifier.scopus84962367607-
dc.identifier.isi000400774200013-
dc.contributor.authorscopusid8654250900-
dc.contributor.authorscopusid7202544866-
dc.contributor.authorscopusid55408574200-
dc.contributor.authorscopusid7406037925-
dc.contributor.authorscopusid24450657100-
dc.contributor.authorscopusid7202430759-
dc.contributor.authorscopusid24335829400-
dc.contributor.authorscopusid7003668552-
dc.contributor.authorscopusid55415591100-
dc.contributor.authorscopusid56582552600-
dc.contributor.authorscopusid7202723590-
dc.contributor.authorscopusid56502140300-
dc.identifier.eissn1969-6213-
dc.description.lastpagee1290en_US
dc.identifier.issue11-
dc.description.firstpagee1283en_US
dc.relation.volume11en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid343824-
dc.contributor.daisngid77557-
dc.contributor.daisngid67522-
dc.contributor.daisngid1673863-
dc.contributor.daisngid452208-
dc.contributor.daisngid156230-
dc.contributor.daisngid27034269-
dc.contributor.daisngid4871282-
dc.contributor.daisngid14736968-
dc.contributor.daisngid13504958-
dc.contributor.daisngid74576-
dc.contributor.daisngid476437-
dc.description.numberofpages8en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Ojeda, S-
dc.contributor.wosstandardWOS:Pan, M-
dc.contributor.wosstandardWOS:de Lezo, JS-
dc.contributor.wosstandardWOS:Martin, P-
dc.contributor.wosstandardWOS:Mazuelos, F-
dc.contributor.wosstandardWOS:Romero, M-
dc.contributor.wosstandardWOS:Novoa, J-
dc.contributor.wosstandardWOS:Espejo, S-
dc.contributor.wosstandardWOS:Segyra, J-
dc.contributor.wosstandardWOS:Morenate, C-
dc.contributor.wosstandardWOS:Medina, A-
dc.contributor.wosstandardWOS:de Lezo, JS-
dc.date.coverdateFebrero 2016en_US
dc.identifier.ulpgces
dc.description.sjr1,94
dc.description.jcr5,193
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Morfología-
crisitem.author.orcid0000-0002-2378-3242-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameMartín Rodríguez, Patricia-
Appears in Collections:Artículos
Show simple item record

SCOPUSTM   
Citations

9
checked on Mar 24, 2024

WEB OF SCIENCETM
Citations

8
checked on Feb 25, 2024

Page view(s)

63
checked on Feb 18, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.